CoChat

Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia

Open access
Swinnen, S. G. H. A., Mullins, P., Miller, M., Hoekstra, J. B. L., Holleman, F. · 2009 · Diabetologia

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

AIMS/HYPOTHESIS: The aim of this analysis was to quantify the relationship between the frequency of hypoglycaemia and various glucose cut-off points for the definition of hypoglycaemia, within a range of HbA(1c) strata. METHODS: Data from two trials examining insulin glargine dose titration in 12,837 type 2 diabetic participants starting insulin therapy were combined. Curves for hypoglycaemia frequency plotted against endpoint HbA(1c) level were constructed, using a range of glucose cut-off points for hypoglycaemia. RESULTS: During the 12-week study period, 3,912 patients recorded 21,592 hypoglycaemic episodes, comprising 242 severe, 8,871 symptomatic and 12,479 asymptomatic events, corresponding to hypoglycaemia event rates of 0.10, 3.8 and 5.3 events per patient year. Increasing the hypoglycaemia cut-off point from, for instance, <3.1 to <3.9 mmol/l more than doubled the percentage of affected patients, e.g. from 17.7 to 43.3% at HbA(1c) 7.0-7.2%. At higher hypoglycaemia cut-off points the proportion of patients having only asymptomatic hypoglycaemia increased, e.g. from 30.7% at <3.1 mmol/l to 61.7% of patients at a cut-off point of <3.9 mmol/l. In sensitivity analysis, 121 of 1,756 patients with at least one self-monitored blood glucose value <3.1 mmol/l experienced severe hypoglycaemia, compared with 149 of 3,912 patients with a self-monitored blood glucose level of <3.9 mmol/l. Thus, to identify 28 more patients with severe hypoglycaemia, the number of patients experiencing only non-severe hypoglycaemia more than doubled. CONCLUSIONS/INTERPRETATION: The glucose cut-off point defining hypoglycaemia greatly affects the reported frequency of hypoglycaemia. When hypoglycaemia is to be defined by a predetermined glucose level, to have clinical relevance the cut-off should be set at a lower level than the threshold of 3.9 mmol/l proposed by the American Diabetes Association.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-008-1147-0

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Proportion of patients experiencing at least one nonsevere hypoglycaemic episode during the 12-week analysis period for a range of predefined glucose cut-off points for the definition of hypoglycaemia, plotted against endpoint HbA1c categories
Fig. 1 Proportion of patients experiencing at least one nonsevere hypoglycaemic episode during the 12-week analysis period for a range of predefined glucose cut-off points for the definition of hypoglycaemia, plotted against endpoint HbA1c categoriesCC-BY-NC · From the PDF
Fig. 2 Proportion of patients experiencing only asymptomatic nonsevere hypoglycaemic episodes during the 12-week analysis period (black bars) vs proportion of patients also experiencing symptomatic hypoglycaemic episodes (white bars), for a range of predefined glucose cut-off points for the definition of hypoglycaemia
Fig. 2 Proportion of patients experiencing only asymptomatic nonsevere hypoglycaemic episodes during the 12-week analysis period (black bars) vs proportion of patients also experiencing symptomatic hypoglycaemic episodes (white bars), for a range of predefined glucose cut-off points for the definition of hypoglycaemiaCC-BY-NC · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 52

Metadata

Authors
Swinnen, S. G. H. A., Mullins, P., Miller, M., Hoekstra, J. B. L., & Holleman, F.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • University of Auckland (NZ)
  • Sanofi (France) (FR)
Corresponding author
Swinnen, S. G. H. A.
Venue
Diabetologia
Published
2008-09-20
Volume
52
Issue
1
Pages
38-41
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2083554831
Cited by
52
References
12
Citations by year
2025: 1 · 2024: 1 · 2021: 2 · 2020: 1 · 2018: 6 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 10 · 2013: 7 · 2012: 6
FWCI
2.41
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Diabetologia (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
Funders
  • Sanofi
  • Novo Nordisk
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
Keywords
hypoglycemia, HbA1c, type 2 diabetes, insulin glargine, insulin dose adjustment, self-monitoring of blood glucose, severe hypoglycemia, hypoglycemia risk
MeSH terms
Awareness, Blood Glucose, Clinical Trials as Topic, Diabetes Mellitus, Glycated Hemoglobin, Humans, Hypoglycemia, Insulin, Incidence, History, 17th Century

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. https://app.cochat.ai/papers/10.1007/s00125-008-1147-0
The paper
Swinnen, S. G. H. A., Mullins, P., Miller, M., Hoekstra, J. B. L., & Holleman, F. (2009). Changing the glucose cut-off values that define hypoglycaemia has a major effect on reported frequencies of hypoglycaemia. Diabetologia. https://doi.org/10.1007/s00125-008-1147-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.